SCHEMBL4150870

SCHEMBL4150870

CN(C(=O)c1c(F)cccc1F)C(=O)N(C)c1ccc(SC(Cl)(Cl)Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.39
TLR7 Q9NYK1 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
GPBAR1 Q8TDU6 3/20 0.35
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
POLB P06746 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
NR1H2 P55055 1/20 0.30
NR1H3 Q13133 1/20 0.30
EGFR P00533 1/20 0.30
ERBB2 P04626 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4159049 0.89 TLR7 (0.39) RORCTLR7TDP1GPBAR1ESR1
SCHEMBL4150864 0.85 TDP1 (0.41) RORCTLR7TDP1GPBAR1ESR1
SCHEMBL4912606 0.81 GPBAR1 (0.49) RORCTLR7TDP1GPBAR1CES2
SCHEMBL4149997 0.74 RORC (0.41) RORCTLR7TDP1
SCHEMBL4154435 0.73 RORC (0.36) RORCTLR7TDP1GPBAR1CES2
SCHEMBL4156749 0.72 POLB (0.37) RORCTLR7TDP1GPBAR1CES2
SCHEMBL4164252 0.72 RORC (0.40) RORCTLR7TDP1NR1H3
SCHEMBL4155292 0.71 RORC (0.38) RORCTLR7TDP1GPBAR1POLB
SCHEMBL4158854 0.71 RORC (0.35) RORCTLR7TDP1GPBAR1POLB
SCHEMBL4145216 0.71 RORC (0.38) RORCTDP1CES2CES1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 RORC 4448/4885TLR7 905/4885TDP1 1690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.